BRICS chairship passes to China as PM Modi extends best wishes; calls for "concrete results" in grouping’s third decade
September 13, 2026
tribuneindia.com
ST. LOUIS and SHANGHAI, China, Aug. 30, 2021 (GLOBE NEWSWIRE) — Stereotaxis (NYSE: STXS) and Shanghai Microport EP Medtech Co., Ltd. (“ MicroPort EP ”) today announced a broad collaboration to advance technology innovation and commercial adoption of robotics in electrophysiology in China. The agreement brings together MicroPort EP’s commercial and product leadership in China’s electrophysiology market with Stereotaxis’ advanced Robotic Magnetic Navigation technology. As part of the collaboration, MicroPort EP will become the exclusive distributor of Robotic Magnetic Navigation technology for electrophysiology in China. MicroPort EP will also pursue regulatory approvals for Stereotaxis’ latest innovations including the Genesis RMN®…
